SEC Form 4 · accession 0000899243-18-016225
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jordan G Naydenov
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 12, 2018 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.49 | Jun 8, 2018 | A | 100,000 | A | — | Jun 8, 2028 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The options will vest in four equal quarterly installments commencing on September 1, 2018.